Viewing data from:

CARBIDOPA AND LEVODOPA

ANDA

CARBIDOPA; LEVODOPA | A075091 | MYLAN PHARMACEUTICALS INC

2 strengths0 unique patents0 unique exclusivities

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Jun 24, 2004	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (2)

Sort:

#001 — 50MG;200MG

0 patents0 exclusivities▴

TABLET, EXTENDED RELEASE;ORAL | Approved: Sep 30, 1999

No patent or exclusivity listings for this strength.

#002 — 25MG;100MG

0 patents0 exclusivities▾

TABLET, EXTENDED RELEASE;ORAL | Approved: Apr 21, 2000